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Abstract: Visceral leishmaniasis (also known as kala-azar)
is classified as one of the most neglected tropical diseases.
It is becoming a growing health problem in Ethiopia, with
endemic areas that are continually spreading. The annual
burden of visceral leishmaniasis (VL) in Ethiopia is
estimated to be between 4,500 and 5,000 cases, and the
population at risk is more than 3.2 million. There has been
a change in the epidemiology of VL in Ethiopia. Over the
last decades, almost all cases and outbreaks of VL were
reported from arid and semi-arid parts of the country;
however, recent reports indicated the introduction of this
disease into the highlands. Migration of labourers to and
from endemic areas, climatic and environmental changes,
and impaired immunity due to HIV/AIDS and malnutrition
resulted in the change of VL epidemiology. HIV spurs the
spread of VL by increasing the risk of progression from
asymptomatic infection towards full VL. Conversely, VL
accelerates the onset of AIDS. In Ethiopia, VL epidemiol-
ogy remains complex because of the diversity of risk
factors involved, and its control is becoming an increasing
challenge. This paper reviews the changes in epidemiol-
ogy of VL in Ethiopia and discusses some of the possible
explanations for these changes. The prospects for novel
approaches to VL control are discussed, as are the current
and future challenges facing Ethiopia’s public health
development program.
Introduction
Leishmaniases are a group of diseases caused by more than 20
species of the protozoan genus Leishmania that are transmitted
between humans and other mammalian hosts by phlebotomine
sandflies [1]. The disease endangers some 350 million people in 98
countries, most of them in the poorer regions of the globe [2,3].
There are two major clinical forms of leishmaniasis, cutaneous
leishmaniasis (CL) and visceral leishmaniasis (VL) [2]. VL is the
most severe form of leishmaniasis, almost always fatal if untreated
[4,5]. An estimated 200,000 to 400,000 new cases of VL occur
worldwide each year, and from this, greater than 90% of VL
human cases occur in six countries, namely Bangladesh, Brazil,
Ethiopia, India, South Sudan, and Sudan [5]. Eastern Africa has
the second highest number of VL cases, after the Indian
Subcontinent. The disease is endemic in Eritrea, Ethiopia, Kenya,
Somalia, Sudan, South Sudan, and Uganda [6,7].
In Ethiopia, the first case of VL was documented in 1942 in the
lower Omo plains, the southwestern part of the country [8]. The
disease has spread to become endemic in many parts of the
country. The disease is prevalent mostly in lowland, arid areas,
and the parasite involved is mainly Leishmania donovani, with an
estimated annual incidence of more than 4,000 cases [9]. Most
important endemic foci include the Humera and Metema plains in
the northwest [10], the Omo plains, the Aba Roba focus, and the
Weyto River Valley in the southwest [11,12].
In Ethiopia, VL mainly occurs in the arid and semi-arid areas;
however, recent reports indicate spreading of the disease to areas
where it was previously non-endemic [6,13–16]. In 2003, an
outbreak of VL occurred in highland areas of the Libo Kemkem
district, in the Amhara regional state [16]. This is the only
recorded VL outbreak from highland areas in Ethiopia; however,
Ashford et al. [17] reported a few cases of VL in Belessa, a
highland area in the Amhara regional state in the 1970s.
VL is becoming a growing public health threat; the spatial
distribution and burden of VL is upsurging year after year [18].
VL–HIV co-infection is rising in Ethiopia, and it poses a new and
difficult challenge to VL control effort. VL–HIV co-infection is
characterized by a number of complexities, including challenging
diagnosis, increased drug toxicity, and poor treatment response.
Leishmaniasis in Ethiopia was formerly overseen by the Ministry
of Health (MoH), but after the MoH underwent a large
reorganisation in 2007, a national leishmaniasis task force was
established with the aim of eliminating VL by 2015. Efforts made
by the MoH so far to control VL are not withstanding its upsurge
and, hence, VL is developing both on a spatial and temporal basis.
Considering its recent upsurging, we thoroughly reviewed and
analysed the previous works done, and we also propose a way
forward to tackle this disease.
Visceral Leishmaniasis in Ethiopia
1.1. Etiology
Leishmaniasis is caused by obligate intracellular protozoa of the
genus Leishmania, belonging to the family Trypanosomatidae
(order Kinetoplastida) [19,20]. Human infection is caused by
about 21 of 30 species that infect mammals. Leishmania donovani
complex (L. donovani and Leishmania infantum) are the causative
agents of VL in Ethiopia. L. donovani is regarded as the major
cause of VL in Ethiopia, although L. infantum was identified as a
main causative agent of the recent VL outbreak in Libo Kemkem,
in the Amhara regional state [6,16].
1.2. Hosts
Man and dogs are the most commonly affected hosts, and they
can also be a potential reservoir [19,20]. Dogs are the most
important species among domesticated animals in the epidemiol-
ogy of this disease, hence, dogs are reservoir hosts for L. infantum,
which is one of the two most important organisms in human VL
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[19,20]. According to Dereure et al. [21], domestic dogs might be
the most important reservoir of L. donovani in eastern Africa.
Some recent studies conducted by Bashaye et al. [22] in northern
Ethiopia and Hassan et al. [23] in eastern Sudan also reported
isolation of L. donovani complex from dogs. Moreover, Hassan et
al. [23] reported highly significant attraction of different sandfly
species to dog-baited traps. On the other hand, in East Africa, the
transmission of L. donovani (the predominant causative agent of
VL in the region) is thought to be anthroponotic, indicating that
humans are a potential reservoir host for the disease [24]. Hence,
the definitive reservoir of VL in East Africa in general and
Ethiopia in particular remains to be determined.
A previous study conducted to determine the natural blood
meal source of the sandfly in northern Ethiopia revealed a
remarkably high bovine blood feed. The ELISA-based blood meal
analysis of 273 fresh fed Phlebotomus orientalis females collected
from Metema showed 92% of their blood meal source to be from
bovine origin [25]. However, epidemiological significance of
bovine in the transmission of leishmaniasis has not yet been
investigated.
1.3. Life cycle and transmission
The life cycle of the Leishmania parasite is completed in two
hosts, a vertebrate host and an invertebrate host (phlebotomine
sandfly) [20]. The parasites exist in two main morphological forms:
the amastigotes in vertebrate hosts and promastigotes in inverte-
brate hosts [19]. The life cycle starts when the sandfly injects the
infective stage (i.e., promastigotes) from its proboscis during blood
meal. The promastigotes are then phagocytosed by the host’s
macrophages and other types of mononuclear phagocytic cells.
Promastigotes transform in these cells into amastigotes. The
mononuclear phagocytic cells lyses and then the amastigotes infect
other phagocytic cells. The adult female sandfly is a bloodsucker,
and when the fly bites a host infected with Leishmania, the
amastigotes are ingested along with the blood meal. In the sandfly,
amastigotes develop into promastigotes in the gut, and then migrate
to the proboscis and the cycle continues when the sandfly injects the
promastigotes into the skin of the host during blood meal [19,20].
The life cycle of the Leishmania parasite is indicated in Figure 1.
Transmission of Leishmania parasites can be zoonotic (i.e., from
animals such as dogs and rodents to humans) or anthroponotic (i.e.,
from infected humans to non-infected humans) [20].
1.4. Vector ecology
There are about 30 species of phlebotomine sandflies known to
transmit leishmaniases [26]. Phlebotomus orientalis, Phlebotomus
martini, and Phlebotomus celiae have been confirmed as vectors of
VL in Ethiopia [6,25,27,28]. The ecological preference of these
flies differs: rainfall, humidity, temperature, soil type and moisture
content, and land cover type are significantly associated with the
distribution pattern of these sandflies, although no universal
pattern has been established so far [27,28]. Changes in temper-
ature, rainfall, and humidity can have strong effects on vectors and
reservoir hosts by altering their distribution and influencing their
survival and population sizes [5].
In the endemic areas of Ethiopia, two distinctive ecologic
settings have been described. In northwestern foci, the principal
vector, P. orientalis, is found in association with black cotton-clay
soils and acacia forests. In southern foci, where P. martini and P.
celiae are believed to transmit the disease, termite hills are thought
to provide resting and possibly breeding sites for sandflies [28].
However, the Libo Kemkem and Fogera districts, which are
affected by the recent epidemic, differ from both of the classic
ecologic settings. These areas are located at an altitude of around
1800m, are substantially cooler, and have different vegetation
from other endemic areas in the lowland areas [15,22]. The vector
species in this area has yet to be identified. However, the most
likely vector inhabiting this area is believed to be P. orientalis.
1.5. Distribution
VL is reported to be widespread over the arid and semi-arid parts
of the country. Cases of VL have been reported from six regions
(Tigray, Amhara, Oromia, Southern Nations and Nationalities
People’s Region (SNNPR), Somali, and Afar regional states), and
serologically positive cases were reported from Gambela and
Benshangul Gumuz regional states [29,30]. The most important
endemic foci include the Metema and Humera plains in northern
Ethiopia, the Omo plains, and the Aba Roba focus andWeyto River
Valley in SNNPR. The disease was also reported from the Moyale
area and Genale river basin in the Oromia regional state, Afder, and
Liban zones in Ethiopia’s Somali region, and the Awash Valley in
the Afar regional state [6,12,14,31]. Summary of VL foci in Ethiopia
is detailed in Table 1 and illustrated pictorially in Figure 2.
1.6. Risk factors
Different risk factors are known to engage in the epidemiology
of VL. In endemic areas, more cases occur in younger age groups
as they have yet to develop the acquired immunity. In East Africa,
approximately 65% of VL cases are found in children less than 15
years old [18]. However, in outbreaks or areas where the disease
has recently been introduced, all age groups are susceptible and
most cases occur in groups that have regular contact with sandfly
habitats [32]. Males are more predisposed to develop the disease
as they are usually engaged in outdoor activities, which will make
them more accessible to the sandfly bite [6].
Poor protein, energy, iron, vitamin A, and zinc nutritional status
increase the risk of VL manifestation [19]. Malnourished children,
who often suffer simultaneously from associated diseases such as
tuberculosis, respiratory and/or intestinal infections are particularly
vulnerable [5,18]. A study conducted by Mengesha [33] indicated a
significant association between severe malnutrition and intestinal
parasitic infection, and VL. Malnutrition and intestinal helminth
infection down-regulate the Th1 cellular immune response. Down-
regulation of Th1 cellular immune response confers susceptibility to
VL. Studies show that periodic regular deworming reduced
malnutrition significantly, and supplementation of micronutrients
such as zinc and iron, as well as vitamin A, improve malnutrition
and enhance Th1 cellular immune response. Thus, periodic
deworming and micronutrient and vitamin A supplementation
together may reduce the risk of symptomatic VL [34].
Poverty increases the risk for VL. Poor housing and poor
sanitary conditions may increase sandfly breeding and resting sites,
as well as their access to humans. The flies are mainly attracted to
crowded housing, as these provide a good source of blood-meals
[5]. Sleeping outside or on the ground may increase the risk of
infection. This is especially more evident in nomadic populations
and in men who work in agricultural or pastoral settings due to
increased time spent outdoors and thus higher exposure to the
sandfly. Part of a community that lives and/or has frequent
contact with acacia trees and termite hills are at increased risk,
since acacia trees and termite hills are common breeding and
resting sites for certain species of sandflies [5,14].
Epidemics of leishmaniasis are often associated with migration
and the introduction of non-immune people into areas with
existing transmission cycles [19]. In northwestern foci, VL
epidemics are associated with migration and the movement of
non-immune workers into the VL-endemic extensive farm lands
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Figure 1. Life cycle of leishmania parasite [20].
doi:10.1371/journal.pntd.0003131.g001
Table 1. Summary of VL foci in Ethiopia.
Region VL endemic districts/foci Parasite involved Vector involved Reference
SNNPR Omo: Omo plains L. donovani P. orientalis [11,35]
Konso: Segen valley, Weyto valley L. donovani P. martini, P. celiae [12]
Sidamo: lake abaya, Dawa valley, Galena valley L. donovani [6]
Oromia Moyale: Genale valley, Negele borena (Liben district) L. donovani [6,31]
Somali Afder L. donovani [14]
Liban L. donovani [14]
East Imey [46]
Tigray Humera plains: (Kafta Humera and Tsegede,
Tahtay Adiabo districts)
L. donovani P. orientalis [25]
Shiraro district [46]
Raya-Azebo [30]
Amhara Metema: (Armacho district) L. donovani P. orientalis [25]
Libo Kemkem L. donovani, L. infantum P. orientalis [16]
Fogera L. donovani P. orientalis [6]
Afar Awash valley: Mile, Dubty and Asayta L. donovani P. orientalis [41,42]
doi:10.1371/journal.pntd.0003131.t001
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[5]. Workers from the non-endemic highlands are often victims of
VL in these foci.
A recent study conducted by Bashaye et al. [22] investigating
risk factors associated with the outbreak in Libo Kemkem
identified dog ownership to be a risk factor. In Ethiopia, culture
and tradition of inhabitants favours the keeping of dogs in urban
and rural households often in close association with the family and
farm animals. Almost all livestock owners and urban dwellers keep
at least one dog to safeguard their properties from wild carnivores
and thieves. These, and other, socioeconomic realities are
considered to be conducive to the maintenance and further
propagation of the disease.
1.7. Diagnosis and treatment
Currently, clinical diagnosis and the rK39 rapid dip-stick test
(RDT) are used to diagnose VL in health centers, and clinical cases
that are negative with rK39 RDT are referred for further diagnosis
using the direct agglutination test (DAT) and/or lymph node or
bone marrow aspirate at district or zonal hospitals. The first line
treatment for VL in Ethiopia is sodium stibogluconate (SSG), and
the second line treatment to be used in cases of toxicity, relapse,
and treatment failure is amphotericin B [6].
The Changing Epidemiology of VL in Ethiopia
2.1. Historical perspective
The lower Omo plains, in the southwestern foci, are the oldest
known VL focus in Ethiopia, first identified in the 1940s [8].
Southwestern foci include the Omo plains, the Aba Roba focus,
and the Weyto River Valley. In the 1970s, an extensive survey was
conducted in this area [11,35]. These authors reported sporadic
endemicity of VL in these foci, which is characterized by
widespread infection and low incidence affecting mainly children.
Most of the population in this area has been exposed to the disease
and acquired immunity. Fuller et al. [11] reported a prevalence of
64% using the leishmanin skin test. The Segen river (Aba Roba
focus) and the adjoining Woytu river valleys are areas that exhibit
a huge microfocal variation in burden of VL and L. donovani
infection. The unique human adaptation and settlement patterns
of the communities in these areas and the very focal nature of
sandfly habitats are believed to be the major factors for the local
variations in the burden of VL in the valleys [32]. The Aba Roba
focus is especially one of the foci with high VL endemicity and
high population immunity (a significant proportion of Leishmania-
infected individuals does not develop clinical illness but shows
elevated antileishmanial antibodies), with 36.4% testing positive
with the leishmanin skin test [12]. The leishmanin skin test (LST)
is used as an indicator of cell-mediated immunity against
Leishmania parasites. It is believed that the development of a
positive LST correlates with long-lasting protection against
leishmania infection [36].
The other most important VL foci in Ethiopia are the Metama
and Humera plains (northwestern foci) [10,31,37]. These lowland
areas host the largest VL foci in Ethiopia and are adjacent to VL
endemic areas of Sudan [38]. Before the 1970s, only sporadic cases
of VL were known to occur in this area; however, a marked increase
in VL cases occurred during the 1970s. In the Metama and Humera
plains, the disease is particularly associated with migration of non-
immune labourers from the surrounding highlands to the extensive
agricultural farm lands of the Humera and Metema lowlands [39].
The marked increase in cases of VL in the 1970s in this area is also
believed to be associated with the migration of workers from non-
endemic highlands to intensive agricultural farm lands [37,39,40].
Several outbreaks have occurred in these foci; the most recent one
that started in 1995 appeared to bemore serious, claiming the lives of
about 100–200 temporary farm labourers [25]. In the Humera and
Metema plains, more than 2,500 cases of VL were being treated
each year since 1998/1999.
In the lowlands of the northeastern Rift Valley of Ethiopia
(Awash Valley), VL occurs with high population immunity.
However, active case finding surveys by Fuller et al. [41] and Ali
et al. [42] have not documented any confirmed cases of VL. On the
contrary, leishmanin skin test rates remain high in this area. Fuller et
al. [41] reported leishmanin rates of 59.5% among Afar pastoralists
in this area. Recent surveys conducted by Ali et al. [42] in the lower
Awash Valley have documented an average leishmanin skin test rate
of 40%. No recent clinical case or suspects of VL were apparent in
this area and thus, subclinical cases expected to make the bulk of the
infections. There is no firm evidence as to why clinical cases of VL
are not occurring in any great numbers.
The changing epidemiology of VL is evident in Ethiopia; the
Libo Kemkem and Fogera districts, which are affected by the
recent epidemic, differ from the known epidemiological pattern.
Over the last decades, almost all cases and outbreaks of VL were
reported from arid and semi-arid parts of the country. However,
the Libo Kemkem and Fogera districts, where the recent outbreak
occurred, are highland areas [15,16]. The outbreak began in one
peasant association in 2003, with cases peaking in 2005 and
occurring mainly in the Libo Kemkem and Fogera districts. These
areas have eventually become a low-incidence endemic area by
Figure 2. VL endemic foci in Ethiopia.
doi:10.1371/journal.pntd.0003131.g002
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2007 [16]. This outbreak has claimed 120 lives among 2,450
primary cases that occurred, and it is the first known outbreak
report of VL from the Ethiopian highland [22]. The parasite was
thought to have been introduced by agricultural labourers
returning from seasonal work in the Humera-Metema lowland
areas. High prevalence of positive leishmanin skin tests were found
in returned migrant workers [38].
2.2. Current situation
There is a dearth of recent information on the distribution and
burden of VL in Ethiopia, as there is a poor reporting system of the
cases. According to the MoH [43], the annual burden of VL in
Ethiopia is estimated to be between 4,500 and 5,000 cases.
Unfortunately, this data is unlikely to give a true reflection of the
field condition, as the health facilities where this disease is evident
are not well equipped to identify VL cases. The trend of VL cases
reported and treated between 2004 and 2011 is illustrated in
Figure 3. In the Ethiopian practical context, it is highly likely that
the VL burden might be much more than what is reported, because
of the considerable migration of labourers from the highlands to the
VL endemic lowlands, and foreseen HIV/AIDS epidemics in the
endemic areas. Recently, Tsegaw et al. [30] developed a risk map of
VL in Ethiopia. These authors estimated the total population at risk
to be 3.2 million, based on the national population census of 2007.
According to the risk map, an estimated 375,633 km2 (33%) of the
country’s landmass in northeastern, northwestern, western, and
southeastern parts of the country is highly suitable for VL.
Given the increasing mobility of people and higher HIV–VL
co-infection, there is an impending potential for VL to spread to
the vast and highly populated areas of the country, since the
distribution of the sandfly, a vector of VL, is believed to be more
widespread than the disease.
2.3. Factors influencing the changing epidemiology
2.3.1. Population movements. Epidemics of VL are often
associated with migration and the introduction of non-immune
people into areas with existing transmission cycles [19]. The
changing epidemiology of VL in northern Ethiopia could most
probably be linked to this factor. The outbreak of VL, which has
occurred on the border between Kenya, Somalia, and southeast-
ern Ethiopia in 2001 was also associated with migration of
Leishmania infected population seeking food [14]. Population
movements may also spread the disease, with the return of infected
migrants to non-endemic areas. The source of infection for the
recent outbreak in the Libo Kemkem and Fogera districts was also
hypothesized to be migrant agricultural labourers returning to
their villages from VL endemic areas [16,22].
2.3.2. Environmental and climatic changes. The occur-
rence and distribution of VL is strongly affected by environmental
and climatic factors. Changes in temperature, rainfall, and
humidity and other climatic factors have the potential to alter
the geographic range of VL and its vectors [5]. In most endemic
regions, VL is characterized by a patchy distribution, with discrete
transmission foci. Microecological conditions affect the distribu-
tion of the vector, parasite, and the reservoir host by altering their
establishment and survival [19]. A study was conducted in
Ethiopia to identify environmental parameters influencing the
geographical distribution of VL [30]. According to this study,
annual average temperature shows a high leverage on VL
occurrence (33%), and soil type is the second most important
determinant (27%). Environmental changes that can affect the
epidemiology of VL also include unplanned urbanization,
deforestation, and the incursion of agricultural farms and
settlements into forested areas [19,30].
2.3.3. Malnutrition and HIV co-infection. VL is an
opportunistic disease. Immune suppression mainly due to malnu-
trition and co-infection with the human immunodeficiency virus
(HIV) are among the factors believed to contribute to (re-
)emergence of VL in Ethiopia [30,44,45]. The spread of HIV/
AIDS to rural areas where VL is endemic has resulted in a
progressive increasing overlap between the two diseases. Poor
nutrition, HIV, and intestinal parasitic infections play a role in
influencing the course of the disease by compromising patients’
immunity [33]. The number of VL cases associated with
immunosuppression has increased regularly over the past 15 or
so years. According to a study conducted by Mengesha [33],
among 403 adult VL patients examined in Northwest foci 385
(95.5%) were malnourished.
Current Challenges
Probably the biggest challenge in the control of VL in Ethiopia
is its association with HIV/AIDS, coupled with the seasonal
migration of labourers to and from endemic areas. In northwest
Ethiopia, up to 23% of VL cases are HIV co-infected in 2008, far
higher than anywhere else in the world. The real burden is likely
to be higher, as only 17% of VL cases are screened for HIV in
some facilities [46]. Furthermore, individuals who tested HIV
positive were more than four times more likely to die than those
who tested HIV negative [4]. HIV/AIDS and VL are locked in a
vicious circle of mutual reinforcement. VL accelerates the onset of
AIDS by infecting macrophages throughout the reticuloendothe-
lial system, rendering the body more susceptible by stimulating
replication of the virus. In turn, HIV spurs the spread of VL
[47,48]. According to Sulahian et al. [49], AIDS increases the risk
of VL by 100–1,000 times in endemic areas.
Generally, the public health impact of VL has been grossly
underestimated, mainly due to lack of awareness of its serious
impact on public health development over the last many years.
Endemic regions have been spreading further and there has been a
sustained transmission cycle. The public health impact of VL often
becomes more evident in areas that are remote, where health
facilities are absent or undeveloped [15]. In these areas, most
critical cases are neither treated nor reported, so they act as a
reservoir of infection, passing on the parasite to non-infected
people and keeping the transmission sustained.
Future Needs
The epidemiology of leishmaniasis, especially that of VL, in
Ethiopia is complex, and a number of key questions remain
unanswered. The reservoir hosts for this disease are not well
Figure 3. Trends of VL cases reported and treated by the MoH
[46,52].
doi:10.1371/journal.pntd.0003131.g003
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known and the principal transmission modes are not clearly
defined. As a result, no sound control measure is implemented so
far. Surveillance of active cases and treatment are the major
activities conducted so far by the MoH to control VL. Efforts
made by the MoH to control the disease are suboptimal when
compared to the public health burden the disease poses. Thus, it is
highly likely that VL burden will increase, caused, in part, by the
increasing migration of labourers, climate change, and impaired
immunity.
Measures to control transmission vary according to local
epidemiology [50]. Leishmaniasis control usually relies on case
management (case detection and treatment), vector, and reservoir
control [19]. Early case detection and treatment are essential for
both individual patients and for the community. The treatment
outcome is better in VL patients who are treated in an early stage.
Untreated VL patients act as a source of infection and therefore
contribute to disease transmission in anthroponotic VL areas [44].
In East Africa, up to 50% of the patients with VL develop post-
kala-azar dermal leishmaniasis (PKDL). PKDL is a sequel of VL
that appears as a macular, papular, or nodular rash, usually on the
face, upper arms, trunk, and other parts of the body months after
VL has apparently been cured. People with PKDL are considered
to be a potential source of VL infection [5]. Thus, detection and
treatment of PKDL patients is also likely to be beneficial; however,
the feasibility and impact of PKDL control should have to be
properly evaluated.
Where transmission is intense, case management alone has little
effect, and control of transmission is more important [50].
Interruption of the transmission can be done through vector and/
or parasitic control. Controlling sandflies is an integral component
of leishmaniasis control. Vector control has never been practiced in
the control of leishmaniasis in Ethiopia, and no convincing study
was conducted to determine the role of sandfly control in the
transmission dynamics of VL. In the Indian subcontinent, where
Phlebotomus argentipes is reported to be the vector of VL, vector
control was found to completely control VL [44]. Sandflies are
susceptible to the same insecticides as Anopheles mosquitoes, the
malaria vector. In Ethiopia, there is a massive Anopheles mosquito
control campaign, so sandfly control could be planned alongside the
Anopheles mosquito control campaign. However, it is important to
note that the vector of VL in the Indian subcontinent, P. argentipes,
is restricted to areas in and around the home. The habitat
preference of the major sandflies believed to transmit VL in
Ethiopia should be known before going for vector control. VL
control through sandfly control could be successful, especially in
domestic and peridomestic transmission habitats. The use of
insecticide-treated bed nets (ITNs) prevents VL and other vector-
borne diseases. In Ethiopia, using bed nets was found to decrease
the risk of VL [38]. The use of ITNs avoids human–vector contact
and thereby decreases the chance to be infected and also decreases
the likelihood that sandflies will feed on infected individuals.
However, in Ethiopia, bed net distribution and insecticide spraying
take place in the context of malaria control.
The other most important VL control strategy is reservoir host
control, especially in areas where the principal way of transmission
is zoonotic. In Ethiopia, there is no conclusive evidence whether
the principal way of transmission of Leishmania parasites can be
zoonotic or anthroponotic. Therefore, in-depth studies of the
reservoir hosts and transmission dynamics are very crucial before
going for reservoir host control. Dogs are the main reservoir of
Leishmania parasite, especially L. infantum in zoonotic VL [44].
The efficiency and acceptability of zoonotic VL control based on
surveillance and culling of infected dogs is increasingly being
debated. Treating infected dogs is not an effective control strategy,
as relapses are frequent and dogs can regain infectivity weeks after
treatment, despite being clinically cured. Furthermore, culling of
infected dogs is considered unethical [19,44]. The alternative
approach in reservoir host control is the use of deltamethrine-
treated collars, which reduced the risk of reservoir host infection.
In a study conducted in Iran, using deltamethrine-treated collars
in dogs protects domestic dogs from L. infantum infections and
also reduce the risk of L. infantum infection in children [51].
Conclusions
The epidemiology of VL is complex, and its control is an
increasing challenge. The control measures taken so far cannot
hold out its surge. Meanwhile, there has been a concurrent change
in the epidemiology of VL, and there is an increasing body of
evidence to suggest that the parasite and the vector are more able
to adapt to a new environment than previously thought, as
exemplified by the recent outbreak in highland areas of the Libo
Kemkem and Fogera districts. What is certain is that with the
spread of HIV infection to rural areas and the large-scale
labourers’ migration to and from endemic areas, VL will continue
to pose a major public health problem. In order to reverse the
current VL burden, it is important to understand the transmission
dynamics of the parasite and the habitat preference of the vector.
Therefore, further studies should be conducted to identify the
potential reservoir hosts and to understand the transmission
dynamics, as well as the habitat preference of phlebotomine
sandflies. Further study is also needed to define the effectiveness of
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